Scientists are racing to create a vaccine for COVID-19 in less than one year. Cambridge, Massachusetts based biotechnology company, Moderna, Inc. and the National Institute of Allergy and Infectious Diseases have co-developed the vaccine known as mRNA-1273, which is now in Phase 3 clinical trials with 30,000 adult volunteers. For an update on the phase 3 trials, Newt is joined by Dr. Tal Zaks, Chief Medical Officer at Moderna.
Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Episode 1038: The Global War on God — Dr. Hak Ja Han and the Fight for Religious Liberty
56:39

Episode 1037: How to Win 2026 — Part 5 A Healthier America — Lower Costs, More Choice, Longer Lives
44:20

Episode 1036: How to Win 2026 — Part 4 The American Party — Issues That Poll 70 Percent or Higher
37:28